Citace podle APA

Kienast, A., & Foeldvari, I. (2013). PReS-FINAL-2064: Effect of Goloimumab a new anti-TNF, in patients with the diagnosis of juvenile idiopathic arthritis. BioMed Central.

Styl Chicago

Kienast, A., a I. Foeldvari. PReS-FINAL-2064: Effect of Goloimumab a New Anti-TNF, in Patients With the Diagnosis of Juvenile Idiopathic Arthritis. BioMed Central, 2013.

Citace podle MLA

Kienast, A., a I. Foeldvari. PReS-FINAL-2064: Effect of Goloimumab a New Anti-TNF, in Patients With the Diagnosis of Juvenile Idiopathic Arthritis. BioMed Central, 2013.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..